Results 201 to 210 of about 42,483 (237)
Editorial: Integrative approaches to fibromyalgia: advancing multidisciplinary management strategies. [PDF]
Front Med (Lausanne)Alito A, Fontana JM.
europepmc +1 more source
Exploring Emotional Eating and Emotion Dysregulation in Fibromyalgia Patients: Implications for Disease Management. [PDF]
Healthcare (Basel)Topaloğlu MS, Puşuroğlu M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
BMJ, 2014
Fibromyalgia is a chronic pain condition present in 2-4% of the population. Fibromyalgia consists of widespread pain with similarities to neuropathic pain in clinical findings, pathophysiology, and neuropharmacology. Pain is the predominant symptom and allodynia and hyperalgesia are common signs.
M. Niesters, A. Dahan
+8 more sources
Fibromyalgia is a chronic pain condition present in 2-4% of the population. Fibromyalgia consists of widespread pain with similarities to neuropathic pain in clinical findings, pathophysiology, and neuropharmacology. Pain is the predominant symptom and allodynia and hyperalgesia are common signs.
M. Niesters, A. Dahan
+8 more sources
Clinics in Plastic Surgery, 2020
Fibromyalgia is characterized by generalized pain, specific sites of musculoskeletal tenderness, fatigue, sleep disturbance, headaches, and many other visceral and cognitive maladies. The epidemiology is not well-elucidated and the diagnoses and management can be difficult.
Michael W, Neumeister +1 more
openaire +4 more sources
Fibromyalgia is characterized by generalized pain, specific sites of musculoskeletal tenderness, fatigue, sleep disturbance, headaches, and many other visceral and cognitive maladies. The epidemiology is not well-elucidated and the diagnoses and management can be difficult.
Michael W, Neumeister +1 more
openaire +4 more sources
Journal of Pain & Palliative Care Pharmacotherapy, 2016
Questions from patients about pain conditions and analgesic pharmacotherapy and responses from authors are presented to help educate patients and make them more effective self-advocates. In reply to a question about fibromyalgia, the authors discuss symptoms, the use of opioids and naltrexone, other medication and nonmedication options, and managing ...
Joseph, Johnson, Samir, Sheth
openaire +2 more sources
Questions from patients about pain conditions and analgesic pharmacotherapy and responses from authors are presented to help educate patients and make them more effective self-advocates. In reply to a question about fibromyalgia, the authors discuss symptoms, the use of opioids and naltrexone, other medication and nonmedication options, and managing ...
Joseph, Johnson, Samir, Sheth
openaire +2 more sources
Baillière's Clinical Rheumatology, 1995
The article details the history, concept, definition and assessment of the still enigmatic condition of 'fibrositis' or, as it has more recently been called, 'fibromyalgia'. The concept and diagnosis became popular, especially in North America, in the 1970s, after the seminal publications of Hugh Smythe (1972) and Smythe and Moldofsky (1977).
H, Raspe, P, Croft
openaire +2 more sources
The article details the history, concept, definition and assessment of the still enigmatic condition of 'fibrositis' or, as it has more recently been called, 'fibromyalgia'. The concept and diagnosis became popular, especially in North America, in the 1970s, after the seminal publications of Hugh Smythe (1972) and Smythe and Moldofsky (1977).
H, Raspe, P, Croft
openaire +2 more sources
Best Practice & Research Clinical Rheumatology, 2011
Chronic pain in fibromyalgia patients, together with its associated symptoms and co-morbidities, is now considered a result of dysregulated mechanisms in the central nervous system (CNS). As fibromyalgia patients often report sleep problems, the physiological processes that normally regulate sleep may be disturbed and overlap with other CNS ...
Spaeth M., Rizzi M., Sarzi-Puttini P.
openaire +3 more sources
Chronic pain in fibromyalgia patients, together with its associated symptoms and co-morbidities, is now considered a result of dysregulated mechanisms in the central nervous system (CNS). As fibromyalgia patients often report sleep problems, the physiological processes that normally regulate sleep may be disturbed and overlap with other CNS ...
Spaeth M., Rizzi M., Sarzi-Puttini P.
openaire +3 more sources
Scandinavian Journal of Rheumatology, 1992
(1992). Fibromyalgia and Magnesia. Scandinavian Journal of Rheumatology: Vol. 21, No. 4, pp. 206-206.
E, Prescott +3 more
openaire +2 more sources
(1992). Fibromyalgia and Magnesia. Scandinavian Journal of Rheumatology: Vol. 21, No. 4, pp. 206-206.
E, Prescott +3 more
openaire +2 more sources